The use of genomics in assisted reproduction has transformed IVF around the world. In this recorded webinar, you will join us for a rediscovery of Karyomapping PGT-M technology, including the ability to solve challenging cases, and an overview of the pivotal role of the clinician and genetic counsellor.
Understanding Karyomapping for PGT-M, Dr. Senthil Natesan, Vitrolife
Dr. Senthil Natesan, Vitrolife. Dr Natesan joined Vitrolife from Illumina and prior to that was at BlueGnome. Dr Natesan played a leading role in the development of Karyomapping. Dr Natesan obtained his PhD from the University of Cambridge, UK. Dr Natesan is highly experienced in the technique of Karyomapping and will present the basics of the assay and how this is used in PGT-M.
The PGT-M Journey and the Role of the Genetic Counsellor, Karen Sage MSc, Fertility Genetics, United Kingdom
Karen Sage has a Master’s degree in Genetic Counselling and is the UK’s first specialist genetic counsellor in fertility. Initially working alongside Professor Alan Handyside as lead Genetic Counsellor at the Bridge Centre in London, Karen was then invited to join the Care Fertility Group to set up and lead the Genomic Services across the network of IVF clinics. Karen is specialised in genetic counselling of patients undergoing preimplantation genetic testing for monogenic diseases (PGT-M), structural rearrangements (PGT-SR) and aneuploidy (PGT-A). Karen is a founding partner of Fertility Genetics, (www.fertility-genetics.co.uk) where she provides independent consultancy. Karen will share with us her extensive experience in counselling PGT-M patients, the process and some example cases.
Understanding the Clinician’s Perspective: Carrier Screening to Karyomapping, Dr Tristan Hardy, Fertility Specialist at Repromed, Adelaide (Australia)
Dr. Hardy Tristan holds a special interest in helping couples who are planning genetic testing of their embryos, due to genetic conditions identified in previous pregnancies or via carrier screening. Dr Hardy completed his PhD on new methods of PGT-M and is currently completing a fellowship in genetic pathology through SA Pathology and attends the Women’s and Children’s Hospital to review couples who have experienced pregnancy loss or problems with embryo development.
Solving Challenging Cases with Karyomapping, Dr Sharyn Stock-Myer, Scientist in Charge of Monogenic Disorders, Melbourne IVF (Australia)
Dr. Stock-Myer is a pioneer of PGT in Australia, she holds a doctorate in Human Genetics and has worked at Melbourne IVF for more than 12 years, leading the development of PGT for monogenic disorders. Sharyn is an early adopter of the Karyomapping assay, having led both beta testing prior to official launch and the research project that saw the introduction of Karyomapping at Melbourne IVF in 2014.